Are you looking to earn CE/Rx credits when it’s convenient for you at a reasonable price? Do you want to purchase an education program for CE/Rx credit that was hand-selected by a committee of practicing APRNs knowledgeable about the education needs of APRNs in Wisconsin? Think about supporting your professional organization and nursing by checking out WNA’s on-demand video library …..
Select presentations offered live at recent WNA APRN conferences are now being offered as self-study (on-demand) education programs. The available modules review current and identify new evidence-based pharmacologic and clinical approaches to management of common conditions in primary and acute care, with the goals of safe prescribing practice and optimal therapeutic outcomes. Click on the 10 titles below to find a session description, the presenter, and the number of contact hours (including Rx credit) awarded for each, or see the Module Overview listing of all 10 modules.
The cost is $40/module - WNA members receive a discounted rate of $30/module. Cost includes the CE/Rx credit awarded upon completion of each module’s online evaluation. Payment is by credit card through PayPal (no PayPal account is required to process payment). CLICK HERE to ORDER a single or multiple modules!
Upon completion of your order, you will immediately receive a separate confirmation email for each module ordered containing your unique Order ID# (needed to complete your evaluation) and three links specific to that module – to the video recording, the handout, and the online evaluation. PLEASE SAVE THE CONFIRMATION EMAILS! If it’s been a few minutes and you haven’t received the email(s), please check your spam/trash folders; it’s not uncommon for confirmation emails to get ‘stuck’ especially if using a work email address. If you don’t find anything in your spam/trash folder, please contact bri@wisconsinnurses.org for assistance.
A few other important points:
- The deadline to view your purchased modules and complete the online evaluation for CE credit is April 1, 2023. The evaluation can be completed right away after viewing the recording or you can complete it later (as long as it’s prior to the deadline). You will not be able to access purchased modules or their evaluations after April 1, 2023.
- Worth repeating … Your Order ID number (found in the order confirmation email) is required to access the evaluation form.
- A Certificate of Completion documenting the contact hours (including pharmacology/Rx hours) earned for completing a module will be emailed immediately after you “Submit Evaluation.”
Interested in purchasing a self-study program? Click here to order!
Continuing Education Credit: Each module offers up to 1.25 contact hours, including some portion of which have been designated as ‘pharmacology’ content (see Module Overview document for details). It is the responsibility of participants to determine whether the content provided meets the specific continuing education requirements of their certifying or licensing body.
Requirements for Successful Completion: Participants must view the entire video, review the handout file and complete the online conference evaluation by April 1, 2023 to receive the contact hours for each module purchased.
Relevant Financial Relationships: There are no relevant financial relationships with ineligible companies for those involved with the ability to control the content of this activity with the following exceptions:
- Module #1: Dr. Michael M. Miller – Speaker for Alkermes; Advisor for US WorldMeds, LLC
- Module #3: Dr. Myrtle Wilhite – Stock Owner and Consultant for A Woman’s Touch Sexuality Resource Center
- Module #5: Dr. Audrey M. Stevenson - Speaker for Sanofi Pasteur and Merck
All of the relevant financial relationships listed for these individuals have been mitigated.
Provider Statement: Wisconsin Nurses Association is approved with distinction as a provider of nursing continuing professional development by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
The Office-Based Use of Pharmacotherapy in the Treatment of Opioid Use Disorder
Presenter: Michael M. Miller, MD, DFASAM, DLFAPA - Interim Medical Director, Connections Counseling, LLC
An overview of how to treat addiction in an office-based setting as a non-specialist, focusing on the prescribing of buprenorphine products and long-acting injectable naltrexone as Medications for Opioid Use Disorder (MOUD).
Learning Objectives: You should be able to...
- Explain to patients the indications and potential adverse effects of FDA-approved medications to treat addiction involving opioid use.
- Amend your own treatment approaches in the face of patients’ exposure to illicit fentanyl and analogues.
- Evaluate a patient’s request to discontinue pharmacotherapy for addiction, including whether to taper and the risks associated with discontinuation of maintenance therapy.
- Implement strategies for safe discontinuation of methadone and buprenorphine.
Video duration: 55 minutes
1.00 contact hour / 1.00 Rx
Hyperglycemia & Venous Reflux: Two Chronic Conditions and the Ulcers that Result
Presenter: Latisha Smith-Chase, MD - Medical Director, Fort HealthCare Wound & Edema Center
Reviews what constitutes chronic wound care and how wounds heal. Addresses the pathophysiology of venous leg ulcers and their management. Addresses the pathophysiology and management of diabetic foot ulcers. Focus is on the primary care setting. A brief overview of advanced therapeutics currently available is included.
Learning Objectives:
- Understand how venous leg ulcers occur and are managed
- Understand how diabetic foot ulcers occur and are managed
- Become familiar with some advanced therapies for chronic wounds
Video duration: 1 hour 15 minutes
1.25 contact hours / 1.25 Rx
Updates in Vaginal Health
Presenter: Myrtle Wilhite, MD, MS - Medical Director, A Woman’s Touch Sexuality Resource Center
After a brief background of basic vaginal anatomy, physiology and microbiome homeostasis, the presentation includes common clinical cases primarily focusing on iatrogenic and natural postmenopausal issues. Presenter briefly covers the pros and cons of most available prescriptions and non-prescription options for addressing vaginal health, and vaginal dryness in particular. Topics include:
- Definition and prevalence of vaginal dryness
- Histology and physiology of vagina
- Case studies highlighting specific causes and remedies
Video duration: 1 hour 15 minutes
1.25 contact hours / 1.00 Rx
Diabetes, Comorbidity, Complexity, and Age: Case Review Studies
Presenter: Trudy Mara, RN, MS, FNP-C, GNP-C, ADM-BC, CDE - Nurse Practitioner, SSM Health Wisconsin-Baraboo Clinic
In-depth review of complex case studies involving counseling, medical decision making and follow-up for diabetic patients including: Counseling the new diabetic person; The basal insulin start; Adding a bolus insulin; Adding a GLP-1; The patient with CAD; Determining whether Type 1 and Type 2 diabetes; The elderly, frail diabetic; The morbidly obese patient, Diabetes in the face of end stage renal disease.
Video duration: 55 minutes
1.00 contact hour / .75 Rx
Adult Vaccination Update 2021: Taking a Shot at Protecting Your Female Patients
Presenter: Audrey M. Stevenson, PhD, MPH, MSN, FNP-BC - Division Director Family Health, Salt Lake County Health Department
Vaccines are one of the most important preventive measures we can use to protect our patients against vaccine-preventable diseases. Many of our female patients are missing several of the vaccines that could prevent preventable many communicable diseases and cancers. This fast-paced session will provide the clinician with the most current information on the vaccines recommended for individuals throughout adulthood. Case scenarios will be used to assist the clinician in providing the patient information to assist in shared clinical decision making and addressing vaccine hesitancy.
Learning Objectives:
- Name the most current adult vaccine updates and the implications for implications for adult health
- Describe strategies for improving vaccine rates among your patients.
- Discuss the latest information on the impact of HPV across the lifespan
- Outline the expanded indications for HPV vaccines.
Video duration: 1 hour 6 minutes
1.25 contact hours / 1.25 Rx
Dementia Management – When Dementia Becomes the Primary Diagnosis
Presenter: Sarah Endicott, DNP, GNP-BC, PMHNP-BC - Clinical Professor, University of Wisconsin-Madison School of Nursing
Discussion of dementia management organized by stage: early, moderate and late. The talk includes guideline-based dementia assessment including pearls for diagnosis. Management strategies include both pharmacologic and non-pharmacological treatments. Concludes with discussion of prevention and management of neuropsychiatric symptoms of dementia in outpatient and long-term care settings.
Video duration: 1 hour 15 minutes
1.25 contact hours / .50 Rx
CBD: A Pharmacist’s Perspective
Presenter: Alexandra Sklansky, PharmD, BCPP - Pharmacist, UnityPoint Health-Meriter
Topics covered include: CBD statistics, CBD makeup, applicable law, pharmacodynamics, pharmacokinetics, efficacy, adverse effects, drug interactions, and example patient cases.
Learning Objectives:
- Describe the current use of cannabidiol (CBD) in the United States
- State what CBD is
- Recall the law surrounding CBD
- Review the proposed mechanism of action and kinetics of CBD
- Discuss efficacy data for CBD
- List adverse effects of CBD
- Use the knowledge learned from this lecture on practice cases
Video duration: 1 hour
1.00 contact hour / .75 Rx
Clinical Lipid Updates: New Drugs & New Insights in Lipidology
Presenter: Sanford Carimi, MD, FACP, FNLA - Physician, Director of UnityPoint-Meriter Lipid Clinic, UnityPoint Health
Discussion of determining risk assessment of who needs treatment with emphasis on the “Intermediate” risk group of if/when to treat. For those who need treatment, understanding basic management of Lipids including some Perles on treating statin intolerant or difficult to get to LDL goal patients, as well as learning about the new medication options including PSCK-9 inhibitor & other newer non-statin drugs.
Overview of CV Risk Stratification:
- Clinical Lipid Basics (very quick review)
- Determining cardiovascular risk assessment of who needs treatment (aka the 2018 Guidelines) with emphasis on the “Intermediate” risk group of if/when to treat.
- Review of 2021 NLA Scientific Statement on CAC scoring to Guide Preventative Strategies for ASCVD risk reductions
- For those who need treatment, understanding basic management of Lipids with some pearls on treating statin intolerant or difficult to get to LDL goal patients, as well as learning about the new medication options including PSCK 9 inhibitor & other newer non-statin drugs.
Video duration: 1 hour 15 minutes
1.25 contact hours / .75 Rx
Anticoagulation, Coagulopathies and Thrombophilia: Evaluation and Treatment Options
Presenter: Cate Ranheim, MD, MMM - Hospitalist/Hematologist, UnityPoint Health
Coagulopathies and thrombophilia are challenging to evaluate and to treat. This case-based session reviews the most common clotting and bleeding disorders, including COVID-related conditions, with a focus on the risk and benefits of specific therapeutics. Participants then work together to solve specific clinical problems following a brief presentation on each topic.
Video duration: 1 hour 6 minutes
1.25 contact hours / 1.00 Rx
Mental Health, COVID, and Change; A status update on coping, caring, and moving forward
Presenter: Jennifer Fiegel-Newlon, DNP, PMHNP, FNP, APNP - Psychiatric Mental Health NP, Gundersen St. Josephs; Clinical Associate Professor, University of Wisconsin-Madison School of Nursing
Discussion of acute treatment options, the impact of COVID on day-to-day mental health, the impacts on people with chronic mental illness, the impacts on children and teens, and how to adapt to prolonged change. Reviews several mental health screening tools for use in clinical setting. Indepth discussion of pharmacologic treatment options, followed by case studies.
Video duration: 1 hour 15 minutes
1.25 contact hours / .75 Rx